Health

Eli Lilly Expands into Hair Loss Treatments

Updated 2026-06-24 20:10 UTC 1 source Neutral

Eli Lilly is investing in Absci, an AI startup developing hair growth medications. This move comes as U.S. health spending has sharply increased due to greater use of GLP-1 drugs and more comprehensive care.

Coverage timeline — 2 articles

STAT News

STAT+: U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care

People are getting more care and using lots of GLP-1 drugs, fueling a sharp increase in health care spending.

2026-06-24 20:00 UTC

STAT News

STAT+: Eli Lilly dives into hair loss treatments with investment in AI startup Absci

Eli Lilly is investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis.

2026-06-24 20:01 UTC